~$8.18MReported value · 50K sh @ $163.56
Stock since the trade −6.4% · S&P 500 +1.2% · to Oct 5
A board member of Target sold $8.18M of Target shares. Nobody planned it ahead of time.
General merchandise retailer.
In the last 90 days, no insider of Target reported an open-market purchase and 3 open-market sales worth about $11M. Members of Congress disclosed 1 trade in its stock. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$152.99
Last 12 months
+71.8%
Market value
$69.5B
S&P 500 +15.8% over the same dates. Prices adjusted for splits and dividends.
Bets against the stock: 16.8M shares sold short (3.7% of shares outstanding), +6.0% vs the previous count, 5.5 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Revenue
$26.5B
+5.3% vs the same quarter a year earlier
Free cash flow, last 12 months
$4.46B
This quarter $2.43B, a year earlier $1.01B
Net debt
$8.81B
Debt $14.2B, cash $5.41B, at Aug 1, 2026
Net income, last 12 months
$4.39B
Operating profit covers interest 14x
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 19, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
3 sales
$11M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2026
$105B
−1.7% vs the year before
Net income, fiscal 2026
$3.71B
As reported in the annual filing
Shares outstanding
454M
As of Aug 21, 2026
In fiscal 2026 the company spent $408M buying back its own shares and $2.05B on dividends. Cash actually paid, from its cash-flow statement.
Stock since the trade −6.4% · S&P 500 +1.2% · to Oct 5
A board member of Target sold $8.18M of Target shares. Nobody planned it ahead of time.
Officer plans to sell ~$8.5M of Target
Planned, from payOfficer plans to sell ~$2.63M of Target
Planned, from payPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
0 approvals or clearances and 1 recall recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
A securities lawsuit naming the company as a defendant was filed on Nov 26, 2025 in the U.S. District Court, D. Minnesota. A filing is an allegation, not a finding.
City of Riviera Beach Police Pension Fund v. Target Corporation, 0:25-cv-04461A securities lawsuit naming the company as a defendant was filed on Nov 24, 2025 in the U.S. District Court, D. Minnesota. A filing is an allegation, not a finding.
Craig v. Target Corporation, 0:25-cv-04434Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). 1 case in that period is closed and not listed. Coverage of court records is not complete, and shareholder derivative suits are not included.
Short sale volume: 60.2% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 51.4%. FINRA daily files, to Oct 5, 2026.
Fails to deliver: 7,450 shares (about $1.27M) were not delivered on time for settlement on Aug 25, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Last 12 months, adjusted daily closes
Adjusted close went from $88.96 on Oct 6, 2025 to $152.99 on Oct 5, 2026 (+72.0%). Disclosed activity in the last 12 months: 0 insider purchases, 8 insider sales (3 under pre-arranged plans), 0 Congress purchases, 0 Congress sales.
Vanguard Capital Management
Schedule 13G: passive · filed Apr 30, 2026 · 34M shares
FMR LLC
Schedule 13G: passive · filed Aug 6, 2026 · 24.7M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Top officer leaving
“Cornell stepped down from his position as Chief Executive Officer and will continue to serve as Target’s Executive Chair of the Board.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.